Cong Xiaoming,Sun Xizhao.Metabolic evaluations of pediatric nephrolithiasis[J].Journal of Clinical Pediatric Surgery,,19():661-665.[doi:10.3969/j.issn.1671-6353.2020.08.001]
Metabolic evaluations of pediatric nephrolithiasis
- Keywords:
- Urinary Calculi; Metabolism; Child
- CLC:
- R691.4;R726.9
- Abstract:
- Metabolic evaluations have been a gold standard of etiological diagnosis of nephrolithiasis. Pediatric nephrolithiasis is mostly caused by metabolic disorders and characterized with an earlier onset and an easier recurrence. Therefore it is generally accepted that metabolic evaluations should be performed for pediatric nephrolithiasis. The relevant metabolic parameters should include serum assays, urinalysis, stone composition, and 24h urine collection. In conjunctions with recent guidelines and researches, this article reviewed the metabolic evaluations of pediatric nephrolithiasis and addressed some key issues.
References:
1 Copelovitch L.Urolithiasis in children:medical approach[J].Pediatr Clin North Am,2012,59(4):881-896.DOI:10.1016/j.pcl.2012.05.009.
2 Luo J,Tuerxun A,Shataer A,et al.Kidney stone composition in third-world areas:what Kashgar tells us?[J].J Endourol,2018,32(6):465-470.DOI:10.1089/end.2017.0860.
3 石博文,徐科,黄云腾.经皮肾镜取石术在儿童肾结石中的应用及进展[J].临床小儿外科杂志,2017,16(6):617-621.DOI:10.3969/j.issn.1671-6353.2017.06.021. Shi BW,Xu K,Huang YT.Applications and advances of percutaneous nephrolithotomy in children[J].J Clin Ped Sur,2017,16(6):617-621.DOI:10.3969/j.issn.1671-6353.2017.06.021.
4 张国锋,侯广军,耿宪杰.经皮肾镜取石术治疗小儿复杂肾结石合并上尿路梗阻[J].临床小儿外科杂志,2015,14(1):42-44.DOI:10.3969/j.issn.1671-6353.2015.01.011. Zhang GF,Hou GJ,Geng XJ.Treatment of complex renal calculi and upper urinary tract obstruction with mini-invasive percutaneous nephrolithotomy in children[J].J Clin Ped Sur,2015,14(1):42-44.DOI:10.3969/j.issn.1671-6353.2015.01.011.
5 Tasian GE,Kabarriti AE,Kalmus A,et al.Kidney stone recurrence among children and adolescents[J].J Urol,2017,197(1):246-252.DOI:10.1016/j.juro.2016.07.090.
6 Bastug F,Dusunsel R.Pediatric urolithiasis:causative factors,diagnosis and medical management[J].Nat Rev Urol,2012,9(3):138-146.DOI:10.1038/nrurol.2012.4.
7 Skolarikos A,Straub M,Knoll T,et al.Metabolic evaluation and recurrence prevention for urinary stone patients:EAU guidelines[J].Eur Urol,2015,67(4):750-763.DOI:10.1016/j.eururo.2014.10.029.
8 Pearle MS,Goldfarb DS,Assimos DG,et al.Medical management of kidney stones:AUA guideline[J].J Urol,2014,192(2):316-324.DOI:10.1016/j.juro.2014.05.006.
9 Dion M,Ankawi G,Chew B,et al.CUA guideline on the evaluation and medical management of the kidney stone patient-2016 update[J].Can Urol Assoc J,2016,10(11-12):E347-E348.DOI:10.5489/cuaj.4218.
10 孙西钊,郭宏骞,叶章群.尿结石的代谢评估与预防性治疗[J].临床泌尿外科杂志,2004,19(6):321-324.DOI:10.3969/j.issn.1001-1420.2004.06.001 Sun XZ,Guo HQ,Ye ZQ.Metabolic evaluations and preventive therapy of urolithiasis[J].J Clin Urol,2004,19(6):321-324.DOI:10.3969/j.issn.1001-1420.2004.06.001
11 Tiselius HG.Metabolic risk-evaluation and prevention of recurrence in stone disease:does it make sense?[J].Urolithiasis,2016,44(1):91-100.DOI:10.1007/s00240-015-0840-y.
12 Gabrielsen JS,Laciak RJ,Frank EL,et al.Pediatric urinary stone composition in the United States[J].J Urol,2012,187(6):2182-2187.DOI:10.1016/j.juro.2012.01.124.
13 Sighinolfi MC,Eissa A,Bevilacqua L,et al.Drug-Induced Urolithiasis in Pediatric Patients[J].Paediatr Drugs,2019,21(1):323-344.DOI:10.1007/s40272-019-00355-5.
14 Baldwin DN,Spencer JL,Jeffries-Stokes CA.Carbohydrate intolerance and kidney stones in children in the Goldfields[J].J Paediatr Child Health,2003,39(5):381-385.DOI:10.1046/j.1440-1754.2003.00159.x.
15 Habbig S,Beck BB,Hoppe B.Nephrocalcinosis and urolithiasis in children[J].Kidney Int,2011,80(12):1278-1291.DOI:10.1038/ki.2011.336.
16 Hoppe B,Kemper MJ.Diagnostic examination of the child with urolithiasis or nephrocalcinosis[J].Pediatr Nephrol,2010,25(3):403-413.DOI:10.1007/s00467-008-1073-x.
17 Letendre J,Cloutier J,Villa L,et al.Metabolic evaluation of urinary lithiasis:what urologists should know and do[J].World J Urol,2015,33(2):171-178.DOI:10.1007/s00345-014-1442-y.
18 Lee TT,Elkoushy MA,Andonian S.Are stone analysis results different with repeated sampling?[J].Can Urol Assoc J,2014,8(5-6):E317-E322.DOI:10.5489/cuaj.1872.
19 Nicoletta JA,Lande MB.Medical evaluation and treatment of urolithiasis[J].Pediatr Clin North Am,2006,53(3):479-491.DOI:10.1016/j.pcl.2006.03.001.
20 丛小明,孙西钊,顾晓箭.儿童尿酸氢铵结石的研究进展[J].中华泌尿外科杂志,2017,38(11):879-880.DOI:10.3760/cma.j.issn.1000-6702.2017.11.019. Cong XM,Sun XZ,Gu XJ.Research advances of ammonium acid urate stone in children[J].Chin J Urol,2017,38(11):879-880.DOI:10.3760/cma.j.issn.1000-6702.2017.11.019.
21 那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断指南手册:2014版[M].北京:人民卫生出版社,2014:129-135. Na YQ,Ye ZQ,Sun YH,et al.Chineses Urological Guideline on the Diagnosis of Urologic Disease-2014 Editio[M].Beijing:People’s Medical Publishing House,2014:129-135.
22 Halbritter J,Baum M,Hynes AM,et al.Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis[J].J Am Soc Nephrol,2015,26(3):543-551.DOI:10.1681/ASN.2014040388.
23 Ferraro PM,D’Addessi A,Gambaro G.When to suspect a genetic disorder in a patient with renal stones,and why[J].Nephrol Dial Transplant,2013,28(4):811-820.DOI:10.1093/ndt/gfs545.
24 Monico CG,Milliner DS.Genetic determinants of urolithiasis[J].Nat Rev Nephrol,2011,8(3):151-162.DOI:10.1038/nrneph.2011.211.
25 Wollin DA,Kaplan AG,Preminger GM,et al.Defining metabolic activity of nephrolithiasis-Appropriate evaluation and follow-up of stone formers[J].Asian J Urol,2018,5(4):235-242.DOI:0.1016/j.ajur.2018.06.007.
Memo
收稿日期:2020-07-13。
通讯作者:孙西钊,Email:oneon2n1@163.com